Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400090996Phase 4Not yet recruiting
Phase 4, open-label trial of etanercept, methotrexate and tripterygium wilfordii polyglycosides in rheumatoid arthritis (RA) (2 arms), sponsored by Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Primary endpoints: ACR50, ACR20 and 4 more. Planned start Oct 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400090996.